Pankaj Soni,Rashmi Ranjan Panda,Ganesh Vinayak Gat,Dinesh Kumar,Kamal S. Mehta,Ravikumar Nithiyanandam
申请号：
US15577141
公开号：
US20180207139A1
申请日:
2016.05.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to an immediate release solid oral pharmaceutical composition comprising an effective amount of Tizanidine or its pharmaceutically acceptable salts, esters, solvates, polymorphs, stereoisomers or mixtures thereof. The solid oral dosage form comprises one or more methacrylic acid copolymers or its derivatives and is bioequivalent to the commercially available counterpart (ZANAFLEX® capsule) after oral administration. The invention also relates to a process for preparation of a pharmaceutical capsule dosage form comprising an effective amount of Tizanidine Hydrochloride wherein, the dosage form comprises methacrylic acid copolymer or its derivatives.
